Armentum Partners
Signal active
Investment Firm
Overview
N/A
Highlights
Founded
2012
Industry
Financial Services
Employees
1-10
Investment
116
Lead Investment
4
Exits
67
Stages
N/A
Investor Type
Investment Bank
Location
San Francisco, California, United States, North America
Contact Information
Social
Profile Resume
Armentum Partners, established in 2012 and headquartered in United States, North America., specializes in investments across Biotechnology, Pharmaceutical, Medical, Financial Services, Venture Capital, Finance, FinTech, Banking, Mobile, Telecommunications. The organization boasts a portfolio of 116 investments, with an average round size of $51.4M and 67 successful exits. Their recent investments include InnoPharma, NXT Capital, Comerica Incorporated, Mblox, Norwest Venture Partners. The highest investment round they participated in was $89.7B. Among their most notable exits are InnoPharma and NXT Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Armentum Partners has made 116 investments. Their most recent investment was on Feb 04, 2022, when Lucira Health raised $80.0M.
Armentum Partners has made 18 diversity investments. Their most recent diversity investment was on Oct 05, 2021, when Eloxx raised $30.0M.
investments
116
Diversity investments
18
Lead investments
4
Number of exits
67
Investments
116
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 01, 2022 | Tarsus Pharmaceuticals | Biotechnology | 175.0M |
| Jan 01, 2022 | Coherus Biosciences | Biotechnology | 400.0M |
| Feb 04, 2022 | Lucira Health | Biotechnology | 80.0M |
| Jan 01, 2023 | - | - | 55.0M |
Exits
67
Funding Timeline
Funding rounds
116
Investors
0
Funds
0
Funding Rounds
116
Armentum Partners has raised 116 rounds. Their latest funding was raised on Jan 01, 2023 from a Debt Financing - Groups Recover Together round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 01, 2022 | Post-IPO Debt - Tarsus Pharmaceuticals | - | 175.0M | - |
| Jan 01, 2022 | Post-IPO Debt - Coherus Biosciences | - | 400.0M | - |
| Feb 04, 2022 | Post-IPO Debt - Lucira Health | - | 80.0M | - |
| Jan 01, 2023 | Debt Financing - Groups Recover Together | - | 55.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
Jan 01, 2023
Groups Recover Together raised $55000000 on 2023-01-01 in Debt Financing
Funding Round
Feb 04, 2022
Lucira Health raised $80000000 on 2022-02-04 in Post-IPO Debt
Funding Round
Jan 01, 2022
Coherus Biosciences raised $400000000 on 2022-01-01 in Post-IPO Debt
Funding Round
Jan 01, 2022
Tarsus Pharmaceuticals raised $175000000 on 2022-01-01 in Post-IPO Debt
Funding Round
Jan 01, 2022
Viome raised $20000000 on 2022-01-01 in Debt Financing